The Impact of Body Mass Index on the Analgesic Efficacy of Tegilicine Fumarate in Laparoscopic Surgery: A Single-Center Prospective Observational Study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600121498

Enrollment

Unknown

Registered

2026-03-31

Start date

2026-04-06

Completion date

Unknown

Last updated

2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Group I (BMI 18-24.9 kg/m^2):None

Group II (BMI 25-29.9 kg/m^2):None

Group III (BMI 30-40 kg/m^2):None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic surgery at the First Hospital of Jilin University from 2026 to 2029. 2.Patients who received general anesthesia with tracheal intubation and intravenous patient-controlled analgesia. 3. Patients with complete and accurate medical records and history.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy to analgesic drugs or similar medications. 2. Patients with anxiety, depression, or sleep disorders. 3. Patients with language communication barriers. 4. ASA classification ?.

Design outcomes

Primary

Measure	Time frame
Resting Visual Analog Scale (VASr) Score;	—

Secondary

Measure	Time frame
Patient-Controlled Analgesia Pump Presses;Rescue Analgesic Medication (Tramadol);Hospitalization Cost;Discharge Time;	—

Countries

China

Contacts

Public ContactDong Su

The First Hospital Of Jilin University

dong_su@jlu.edu.cn+86 135 7892 3360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026